Kiromic Biopharma, Inc. vs 4D Molecular Therapeutics, Inc., risk disclosures compared

3topics both disclose

4only Kiromic Biopharma, Inc.

1only 4D Molecular Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Kiromic Biopharma, Inc.	4D Molecular Therapeutics, Inc.
Internal Control	3	6
Restatement	3	5
Ransomware	1	3

Only Kiromic Biopharma, Inc.

Topic	Filings
Artificial Intelligence	23
Data Residency	2
Business Continuity	1
Enforcement Action	1

Only 4D Molecular Therapeutics, Inc.

Topic	Filings
Third Party Risk Management	3

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Kiromic Biopharma, Inc. · 4D Molecular Therapeutics, Inc. · All companies